Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

LipoTherapeia introduces the Celluence® Legs cellulite cream: super-nutrient luxury for legs

The brand new Celluence Legs cellulite cream provides luxury skincare for legs with multiple nourishing supernutrients specific to leg wellness and cellulite, at high concentrations and in high purity


News provided by

LipoTherapeia

Jul 21, 2021, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Celluence® Legs | The leg wellness creams with 9x anti-cellulite actives
Celluence® Legs | The leg wellness creams with 9x anti-cellulite actives

LONDON, July 21, 2021 /PRNewswire-PRWeb/ -- LipoTherapeia, London's skin tightening and cellulite specialists, are launching Celluence Legs, the first cellulite cream in the world with high concentrations of nine extensively researched natural active molecules, specific to leg skin wellness:

  • Curcumin (Turmeric extract)
  • EGCG (Green Tea extract)
  • Asiatic Acid + Madecassic Acid + Asiaticoside (Centella Asiatica extracts)
  • Esculin (Horse Chestnut extract)
  • Forskolin (Coleus Forskohlii extract)
  • Chlorogenic Acid (Green Coffee extract)
  • Caffeine

The idea behind Celluence Legs is for you to apply a luxury cream in the knowledge that you also apply amazing super-nutrients on your legs for skin nourishment, wellness and cellulite prevention and reduction

Post this

All contained in a luxurious, naturally aromatic cream base of extra virgin plum oil.

These actives have been widely used around the world as superfoods, health-promoting drinks or natural remedies for centuries and are known for their action on different aspects of leg skin wellness: hydration, anti-ageing, skin firmness/elasticity, skin microcirculation, stretch marks, cellulite and post-liposuction aftercare.

With its silky skin feel, natural aroma (courtesy of the rare extra virgin plum oil) and skin nourishing actives, the Celluence Legs cellulite cream is ideal as an everyday luxury cream for the legs, thighs and buttocks.

Celluence Legs is based on 20 years of research & experience in leg skin wellness with 3,000 clients and the assessment of 160 active ingredients over 24 months.

Although the cream contains all the important anti-cellulite active molecules, it is not marketed as one of the typical overhyped so-called 'cellulite creams', launched every spring, but rather as primarily a leg skin wellness cream, i.e. a more holistic and down-to-earth focus.

No excessive claims are made and users are encouraged to combine with healthy eating and exercise over a period of 6-12 weeks, instead of being promised 'miracle' results in 1-2 weeks.

"The idea behind Celluence Legs is for you to apply a luxury cream in the knowledge that you also apply amazing super-nutrients on your legs for skin nourishment, wellness and cellulite prevention, i.e. to offer your legs some everyday luxury with benefits", says Georgios Tzenichristos, the creator of Celluence Legs.

"Due to high cost of purified quality active ingredients, most body creams contain very little in the way of actives (in fact, many don't contain any actives at all), and this is where Celluence Legs is different. By doing away with distribution costs, retail markups, expensive packaging and excessive marketing costs, we were able to only focus on active ingredients and the cream itself. The principle is to offer a cellulite cream packed with high-purity, high-concentration actives at a moderate price, providing accessible luxury and quality to all.", explains Georgios.

Celluence Legs is contained in an airless recyclable bottle for maximum freshness and potency. It is absorbed within a couple of minutes and leaves skin hydrated for the whole day without any tackiness or greasiness.

Although the cream has been developed with the needs of leg/buttock skin in mind, it can be used all over the body, except face and neck.

Of course the cream is not tested on animals, does not contain any fragrance or questionable chemicals and is fully compliant to strict UK & EU regulations.

With normal application on legs and buttocks an 100ml bottle (£39, $53) will last 3 weeks. For intensive application over 6 weeks a pack of four bottles is recommended (£132, ~$181).

The Celluence Legs creams are available exclusively direct from the LipoTherapeia website, with tracked delivery to the UK, US, EU/EEA, Australia, Canada and Singapore.

Disclaimer: Results vary from person to person and depending on lifestyle and health status and no specific results are promised.

Media Contact

Georgios Tzenichristos, LipoTherapeia, +44 2071182014, [email protected]

Twitter, Facebook

SOURCE LipoTherapeia

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.